The Seattle Post-Intelligencer said the disease infects one of every three people on Earth, killing 2 million people a year. It is becoming increasingly resistant to drugs.
The foundation, which awarded grants to almost a dozen organizations, gave $7.4 million to Seattle Biomedical Research Institute to dig deeper into the basic biology of the bacteria.
The largest share of the money -- $200 million -- will go to Aeras Global TB Vaccine Foundation of Rockville, Md., to develop new TB vaccines. The money will allow the company to take six experimental vaccines into early-stage clinical testing, the newspaper said Wednesday.